359 related articles for article (PubMed ID: 32807512)
21. Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy.
Massironi S; Viganò C; Dioscoridi L; Filippi E; Pagliarulo M; Manfredi G; Conti CB; Signorelli C; Redaelli AE; Bonato G; Iiritano E; Frego R; Zucchini N; Ungari M; Pedaci M; Bono F; Di Bella C; Buscarini E; Mutignani M; Penagini R; Dinelli ME; Invernizzi P
Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2375-2377. PubMed ID: 32480008
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal manifestations of coronavirus disease 2019.
Joshi T; Ahmed A; Cholankeril G
Curr Opin Infect Dis; 2021 Oct; 34(5):471-476. PubMed ID: 34524198
[TBL] [Abstract][Full Text] [Related]
23. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.
Bostancıklıoğlu M
Inflamm Bowel Dis; 2020 Jul; 26(8):e89-e91. PubMed ID: 32440692
[TBL] [Abstract][Full Text] [Related]
24. Covid-19 and the digestive system.
Wong SH; Lui RN; Sung JJ
J Gastroenterol Hepatol; 2020 May; 35(5):744-748. PubMed ID: 32215956
[TBL] [Abstract][Full Text] [Related]
25. The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.
Wang H; Qiu P; Liu J; Wang F; Zhao Q
Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):653-661. PubMed ID: 32418852
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2-associated gastrointestinal and liver diseases: what is known and what is needed to explore.
Sweed D; Abdelsameea E; Khalifa EA; Abdallah H; Moaz H; Moaz I; Abdelsattar S; Abdel-Rahman N; Mosbeh A; Elmahdy HA; Sweed E
Egypt Liver J; 2021; 11(1):64. PubMed ID: 34777871
[TBL] [Abstract][Full Text] [Related]
27. The Pathophysiology of Gastrointestinal and Hepatic Manifestations of COVID-19.
Yousaf MN; Naqvi HA; Chaudhary F; Raddawi K; Haas CJ
Cureus; 2020 Nov; 12(11):e11698. PubMed ID: 33391931
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.
Tsatsakis A; Calina D; Falzone L; Petrakis D; Mitrut R; Siokas V; Pennisi M; Lanza G; Libra M; Doukas SG; Doukas PG; Kavali L; Bukhari A; Gadiparthi C; Vageli DP; Kofteridis DP; Spandidos DA; Paoliello MMB; Aschner M; Docea AO
Food Chem Toxicol; 2020 Dec; 146():111769. PubMed ID: 32979398
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and Impact of Gastrointestinal Manifestations in COVID-19 Patients: A Systematic Review.
Hossain B; Malik F; Khan A; Abidi M; Marhaba A; Oranu A; Shumeyko M; Hila A; Banks L; Patel OA; Nawaz M; Shaikh S; Nadeem H; Qazi S
J Community Hosp Intern Med Perspect; 2023; 13(3):39-54. PubMed ID: 37877065
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 and its effects on the digestive system.
Cao TT; Zhang GQ; Pellegrini E; Zhao Q; Li J; Luo LJ; Pan HQ
World J Gastroenterol; 2021 Jun; 27(24):3502-3515. PubMed ID: 34239265
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 infection in patients with a normal or abnormal liver.
Cabibbo G; Rizzo GEM; Stornello C; Craxì A
J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
[TBL] [Abstract][Full Text] [Related]
32. Digestive manifestations in COVID-19: Prevalence and prognostic impact.
Elloumi Kharrat H; Ghanem M; Bouchabou B; Bouali R; Elloumi H
Tunis Med; 2020; 98(8-9):643-650. PubMed ID: 33480020
[TBL] [Abstract][Full Text] [Related]
33. Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges.
Su S; Shen J; Zhu L; Qiu Y; He JS; Tan JY; Iacucci M; Ng SC; Ghosh S; Mao R; Liang J
Therap Adv Gastroenterol; 2020; 13():1756284820934626. PubMed ID: 32595762
[TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal manifestations and SARS-CoV-2 infection.
Pizuorno A; Brim H; Ashktorab H
Curr Opin Pharmacol; 2021 Dec; 61():114-119. PubMed ID: 34688995
[TBL] [Abstract][Full Text] [Related]
35. Association of Gastrointestinal System With Severity and Mortality of COVID-19: A Systematic Review and Meta-Analysis.
Menon T; Sharma R; Earthineni G; Iftikhar H; Sondhi M; Shams S; Khurshid Ahmed N; Khan H; Rathore SS; Singh R
Cureus; 2021 Feb; 13(2):e13317. PubMed ID: 33738161
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal and Hepatological Manifestations in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results from the Major COVID Hospital in Serbia.
Mijac D; Vucelj S; Todorovic K; Vojnovic M; Milicic B; Lukic S; Filipovic B; Marjanovic Haljilji M; Popovic D; Adzic Vukicevic T
Microorganisms; 2023 Dec; 12(1):. PubMed ID: 38257854
[TBL] [Abstract][Full Text] [Related]
37. An overview of SARS-COV-2-related hepatic injury.
Tarik Aslan A; Yasemin Balaban H
Hepatol Forum; 2021 Sep; 2(3):122-127. PubMed ID: 35784909
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.
Napodano C; Pocino K; Stefanile A; Marino M; Miele L; Gulli F; Basile V; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U
Scand J Immunol; 2021 Mar; 93(3):e12977. PubMed ID: 32931622
[TBL] [Abstract][Full Text] [Related]
39. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
Khan M; Khan H; Khan S; Nawaz M
J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
[No Abstract] [Full Text] [Related]
40. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19.
Bernard I; Limonta D; Mahal LK; Hobman TC
Viruses; 2020 Dec; 13(1):. PubMed ID: 33375371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
